July 8, US Health Care - Last Week Cheap Fact Sheets

July 8, US Health Care - Last Week Cheap Fact Sheets

Last week the following drugs were FDA approved:

No alt text provided for this image

TAVNEOS?? - adjunctive treatment of adult patients with ‘granulomatosis with polyangiitis’ - caused by inflammation in lungs, throat, etc.?

New Drug Application (NDA): 214487 Company: CHEMOCENTRYX?

ZYDELIG? (idelalisib) tablets, for oral use for the treatment of patients with: chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) in patients; small lymphocytic lymphoma (SLL) New Drug Application (NDA): 205858 Company: GILEAD SCIENCES INC?

TRESIBA? - is a long-acting human insulin analog indicated to improve glycemic control in adults with diabetes. Biologic License Application (BLA): 203314. Company: NOVO?

LEVEMIR?? is a long-acting basal insulin analog, with up to 24 hours duration of action. Biologic License Application (BLA): 021536 Company: NOVO NORDISK INC?

HALOPERIDOL - Abbreviated New Drug Application (ANDA): 200854.?Company: ACTAVIS GROUP, INNOGENIX, MYLAN, SANDOZ, UPSHER SMITH LABS

Last week the following trademarks got under “Published for Opposition” stage:

No alt text provided for this image

PRECISE CREATIVE - Advertising and marketing services provided by means of indirect methods of marketing communications, namely, social media, search engine marketing, inquiry marketing, internet marketing, mobile marketing, blogging and other forms of passive, sharable or viral communications channels

BEST CARE FOR MY PATIENT - Providing an on-line network environment featuring technology that enables users to share data in the field of healthcare, including medical records, patient problems, clinical therapies, practice methods and guidelines, clinical decision support, evidence-based medicine, and other information relating to data analytics and healthcare practices

C - Wallets and wallet inserts

APPOINT - Providing an online non-downloadable Internet-based system application featuring technology enabling users to input multiple variables and constraints to optimize scheduling within organizations

TRAILS TO WELLNESS - Mental health services; Mental health therapy services; Providing a web site featuring information in the field of mental health and wellness; Providing information in the field of mental health and wellness via a website; Providing mental health and wellness information; Providing on-line information in the field of mental health

NUTRICLAD - Chemical ingredients and additives for use in the manufacture of food, beverages, pharmaceuticals, nutraceuticals and cosmetics

PHYTONUTRIAL SOLUTIONS - Chemical ingredients and additives for use in the manufacture of food, beverages, pharmaceuticals, nutraceuticals and cosmetics

TRACHBRIGHT - Medical training and teaching

VENTBRIGHT - Educational services, namely, providing training of nurses for certification in the field of nursing; Medical training and teaching; Providing educational examination for certification in the field of nursing; Providing training for certification in the field of nursing

EL MAESTRO - Disinfectant hand soaps

ESMARTLIFE - Exercise hand grippers.

JOOVVIN’ - Education services, namely, providing online non-downloadable electronic publications in the form of research articles and providing articles and texts of informational interviews in the field of light therapy systems and apparatuses, namely, electronic light therapy systems and apparatuses for skin health, weight loss, athletic performance, muscle recovery, relaxation and sleep, sexual performance, joint pain, mental health, thyroid function, and general wellness.

COMFORT - computer software for use in the medical and healthcare fields relating to home health, palliative, long-term, or hospice care, namely, downloadable and recorded computer software for automating healthcare and administrative processes and for entering, managing, storing, analyzing, maintaining, processing, reviewing, editing, distributing, communicating, organizing, sharing, monitoring, and integrating healthcare information, and instructional user guides sold as a unit.?

LEVINYBABE - Baby feeding pacifiers; Bottle holders for holding babies' bottles

DELLA TERRA PHARMACEUTICALS - botanical pharmaceutical and nutraceutical drug substance and drug product development services; research and development of pharmaceuticals and nutraceuticals

VAVY - Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of COVID-19; Pharmaceutical preparations for use in oncology, oncology supportive care and animal oncology; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of prostate cancer and breast cancer

NEW IPOs:

No alt text provided for this image

Virax Biolabs Group Ltd

VRAX

Virax Cayman is a global innovative biotechnology group that primarily engages in sales, distribution and marketing of diagnostics test kits and med-tech and Personal Protective Equipment (“PPE”) products for the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. Currently, our Group does not manufacture or develop any product…


Nano Labs Ltd

NA

We are committed to the development of high throughput computing, or HTC, chips, high performance computing, or HPC, chips, distributed computing and storage solutions, smart network interface cards, or NICs, vision computing chips and distributed rendering. We have built a comprehensive flow processing unit, or FPU, architecture which offers solution that integrates the features of both HTC and HPC.


Bruush Oral Care Inc.

BRSH

The Company is on a mission to inspire confidence through brighter smiles and better oral health


YUKAI Health Group Ltd

Fuzhou Yukai used to sell medical equipment and serve as distributors for many medical device manufacturers in Fujian province, such as Toshiba, RadioMeter, and GE Healthcare China. In 2016, Fuzhou Yukai’s management decided to adjust its development strategy, taking advantage of its medical equipment selling experience, and entered the outsourced medical equipment maintenance market. We believe we are an expert in managing and maintaining mission-critical, regulated, reusable medical devices. Through Fuzhou Yukai, we offer healthcare providers comprehensive.

Last week the following selective applications are “patent pending” by USPTO

SELECTIVE?

No alt text provided for this image

20220217479 - VAGAL NERVE STIMULATION FOR TREATING DOPAMINE-RELATED CONDITIONS - Vagal nerve stimulation devices and methods are provided for treating medical conditions, such as conditions associated with insufficient dopamine and/or endogenous opioids in the brain. ELECTROCORE, INC Rockaway, NJ, US


20220217290 - IMAGING DEVICE - The present disclosure relates to an imaging device capable of achieving miniaturization and height reduction of a device configuration, reducing generation of a flare or a ghost, preventing separation of a lens.?- SONY SEMICONDUCTOR SOLUTIONS CORPORATION Kanagawa JP

20220217130 - SYSTEM AND METHOD FOR A PATIENT INITIATED MEDICAL INTERVIEW USING A VOICE-BASED MEDICAL HISTORY QUESTIONNAIRE - A system and method for a patient to initiate and complete a voice-enabled, computerized, symptom-based medical history, at the time the patient is concerned about a medical problem.?- Vancho Technical Sales, LLC - Dove Canyon CA

20220213475 - DUAL TARGETING siRNA AGENTS - Alnylam Pharmaceuticals, Inc - Cambridge, MA, US?

20220213482 - TARGETING MISSPLICED TRANSCRIPTS IN GENETIC DISORDERS - Uniqure IP B.V. Amsterdam, NL

20220213448 - VIRAL VACCINES AND METHODS OF FORMING THE SAME - Provided herein is a method for producing an inactivated virus - NDSU Research Foundation Fargo ND US

20220213429 - METHOD AND MEANS FOR OPTIMIZING BIOTECHNOLOGICAL PRODUCTION - A new method for the automatic generation and validation of a Digital Twin for the production of biotechnological products and the application of the Digital Twin for the purpose of increasing product concentration, productivity, biomass concentration and product quality by optimizing media composition and/or feeding profiles. The Digital Twin can be linked directly to production for online optimization or offline for decision support

INSILICO BIOTECHNOLOGY AG Stuttgart DE

20220213197 - MEDICAMENT AND METHOD FOR TREATING INFECTIOUS DISEASES - This invention relates to the field of medicine, particularly to a medicament for treating bacterial infections, which presents a technology-processed product resulting from multiple serial dilutions of the stock substances of antibodies to HLA-DRB1 and antibodies to .beta.2-microglobulin, and to a combination of the claimed medicament with antibiotic, to a method of treating bacterial infections, a method of reducing bacterial resistance to antibiotic therapy and a method of enhancing antibiotic efficacy. - Epshtein, Oleg Iliich Moscow, RU

20220213179 - HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF - Provided herein are humanized anti-factor Bb antibodies, methods of producing the antibodies and methods of using the antibodies.?- Genzyme Corporation Cambridge MA US

20220213146 - STABILIZED PEPTIDES FOR COVALENT BINDING TO TARGET PROTEIN - provided herein is a platform technology for designing stabilized peptides that covalently bind their target protein and thereby inhibit the activity of the target protein. Also provided are exemplary stabilized peptides that can be used for covalent modification of their target proteins.?- Dana-Farber Cancer Institute, Inc Brookline, MA US

20220213103 - 9H-PYRROLO-DIPYRIDINE DERIVATIVES - The invention relates to 9H-pyrrolo-dipyridine derivatives of formula I, processes for preparing them, pharmaceutical compositions containing them and their use as radiopharmaceuticals in particular as imaging agents for the detection of Tau aggregates - UCB Biopharma SPRL, Brussels, BE

20220215969 - METHOD FOR RECOMMENDING CONTINUING EDUCATION TO HEALTH PROFESSIONALS BASED ON PATIENT OUTCOMES - Impactivo, LLC San Juan, PR US

20220215961 - CLINICAL DECISION SUPPORT - KONINKLIJKE PHILIPS N.V EINHOV EN?

20220215957 - Digital Nurse for Symptom and Risk Assessment?- A system and method for intelligent symptom assessment through a machine learning-driven digital assistance platform are disclosed. - Life, Inc Woodbridge CT US

20220214341 - BIOMARKERS AND METHODS FOR ASSESSING PSORIATIC ARTHRITIS DISEASE ACTIVITY - Crescendo Bioscience, Inc. South San Francisco CA

20220213644 - METHOD FOR MAKING ANTIMICROBIAL ARTICLE - A method of making an antimicrobial textile comprising TiO.sub.2 nanoparticles is described. The TiO.sub.2 nanoparticles are immobilized by first treating a textile with a base, and then contacting with TiO.sub.2 nanoparticles in a solution of an alcohol and acid. The textile may be subsequently irradiated with UV light prior to use. The antimicrobial textile shows high effectiveness against the growth and proliferation of microorganisms transmitted within indoor environments.?- Imam Abdulrahman Bin Faisal University Dammam SA

20220213561 - DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS - Natera, Inc San Carlos CA US

20220213495 - METHOD OF PRODUCING MICROBIAL OIL CONTAINING FATTY ACIDS OBTAINED FROM STRAMENOPILE - A method for producing a microbial oil includes the steps of: genetically modifying a labyrinthulid by disrupting and/or silencing a gene, or by transforming another gene in addition to the disruption and/or gene silencing of the gene; culturing the labyrinthulid, such that a fatty acid composition accumulated in the labyrinthulid comprises an increased EPA content; and collecting the microbial oil having the increased EPA content from the labyrinthulid. The increased EPA content is not less than 3.3% of a total fatty acid composition. - NIPPON SUISAN KAISHA, LTD Tokyo JP

20220211836 - INACTIVATED VIRUS COMPOSITIONS AND ZIKA VACCINE FORMULATIONS?- The present invention relates to a liquid inactivated virus composition comprising: an inactivated whole Zika virus, at least one pharmaceutically acceptable buffer with a concentration of at least about 6.5 mM, and optionally a polyol, wherein said at least one pharmaceutically acceptable buffer does not comprise phosphate ions and vaccines derived therefrom.?- Takeda Vaccines, Inc Cambridge MA US

要查看或添加评论,请登录

社区洞察

其他会员也浏览了